We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for... Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Show more
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement PR Newswire TORONTO, March 26, 2024 Proposed business combination to create a North American technology...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement PR Newswire TORONTO, March 25, 2024 Proposed business combination to create a North American technology...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.040499 | 5.32880877788 | 0.760001 | 0.889 | 0.76 | 9295 | 0.80521894 | CS |
4 | -0.3195 | -28.5267857143 | 1.12 | 1.2758 | 0.76 | 22586 | 0.89705302 | CS |
12 | -1.0795 | -57.420212766 | 1.88 | 1.9499 | 0.76 | 18787 | 1.21626203 | CS |
26 | -1.4295 | -64.1031390135 | 2.23 | 2.35 | 0.76 | 14563 | 1.55162718 | CS |
52 | -2.5995 | -76.4558823529 | 3.4 | 3.45 | 0.76 | 75269 | 2.37908139 | CS |
156 | -16.1895 | -95.2884049441 | 16.99 | 17.8 | 0.76 | 300052 | 7.9628918 | CS |
260 | -27.1995 | -97.1410714286 | 28 | 89.8 | 0.76 | 2234738 | 29.50965532 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions